Objective: Early neurologic deterioration has been studied in patients with intracerebral
hemorrhage during hospitalization, but rates and factors associated with prehospital neurologic …

OBJECTIVE: To report the 1-month and intermediate-term results of treatment of symptomatic
intracranial stenosis using drug-eluting stents. BACKGROUND: Patients with intracranial …

Objective: To determine the feasibility and safety of treatment of acute hypertension in patients
with intracerebral hemorrhage within 24 hrs of symptom onset. Elevated blood pressure, …

OBJECTIVE: New approaches are focusing on using a combination of medication that lyse
fibrin and prevent aggregation of platelets to achieve higher rates of recanalization and …

OBJECTIVE: To report the feasibility, safety, and 1-month results of performing stent placement
for vertebral origin stenosis with the use of a distal protection device. Distal protection …

BACKGROUND AND OBJECTIVE: To determine the accuracy of recently introduced International
Classification of Diseases Ninth Revision (ICD-9) procedure and Current Procedural …

Background and Purpose: We prospectively evaluated the safety of aggressive mechanical
disruption of thrombus following full‐dose intravenous (IV) recombinant tissue plasminogen …

BACKGROUND AND PURPOSE Early use of intravenous platelet glycoprotein IIB/IIIA
antagonists after intra‐arterial (IA) thrombolysis may reduce the risk of reocclusion and …

… The rate of underestimation significantly decreased (n=26, 18%, p<0.0001) while the rate of
… 52±12 years; p=0.0001) and had significantly lower median calculated risk (0.95 vs. 3.30; …

The last decade witnessed significant and unprecedented advances in the treatment of acute
ischemic stroke. Intravenous tissue plasminogen activator and defibrinogenating agent are …